Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Payables (2016 - 2025)

Historic Payables for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to $1.3 million.

  • Firefly Neuroscience's Payables fell 267.73% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 267.73%. This contributed to the annual value of $1.8 million for FY2024, which is 18825.4% up from last year.
  • Firefly Neuroscience's Payables amounted to $1.3 million in Q3 2025, which was down 267.73% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Firefly Neuroscience's Payables registered a high of $2.3 million during Q2 2021, and its lowest value of $227560.0 during Q3 2022.
  • Its 5-year average for Payables is $1.1 million, with a median of $789824.0 in 2023.
  • Per our database at Business Quant, Firefly Neuroscience's Payables surged by 130140.46% in 2021 and then crashed by 8929.03% in 2022.
  • Over the past 5 years, Firefly Neuroscience's Payables (Quarter) stood at $650499.0 in 2021, then fell by 11.79% to $573789.0 in 2022, then rose by 9.8% to $630000.0 in 2023, then surged by 188.25% to $1.8 million in 2024, then dropped by 25.94% to $1.3 million in 2025.
  • Its Payables was $1.3 million in Q3 2025, compared to $1.5 million in Q2 2025 and $1.6 million in Q1 2025.